Globe Life (NYSE:GL) Issues FY 2025 Earnings Guidance

Globe Life (NYSE:GL) issued an update on its FY 2025 earnings guidance on Wednesday morning. The company provided EPS guidance of 13.450-14.050 for the period, compared to the consensus EPS estimate of 13.580. The company issued revenue guidance of -.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on the company. Wells Fargo & Company lifted their price objective on Globe Life from $108.00 to $117.00 and gave the company an “overweight” rating in a report on Thursday, October 10th. Morgan Stanley lifted their price target on shares of Globe Life from $110.00 to $120.00 and gave the company an “equal weight” rating in a research report on Thursday, October 24th. Raymond James increased their target price on shares of Globe Life from $160.00 to $188.00 and gave the stock a “strong-buy” rating in a report on Tuesday, October 15th. Evercore ISI upgraded shares of Globe Life from an “in-line” rating to an “outperform” rating and lifted their price target for the stock from $132.00 to $143.00 in a report on Wednesday, January 8th. Finally, Jefferies Financial Group increased their price target on Globe Life from $107.00 to $114.00 and gave the stock a “hold” rating in a report on Tuesday, December 10th. Five research analysts have rated the stock with a hold rating, six have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $132.18.

Globe Life Stock Up 0.4 %

GL traded up $0.52 on Wednesday, hitting $122.93. The company had a trading volume of 587,098 shares, compared to its average volume of 551,996. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.05 and a current ratio of 0.05. The stock has a market capitalization of $10.32 billion, a price-to-earnings ratio of 10.40 and a beta of 0.81. The stock has a fifty day moving average price of $112.78 and a 200-day moving average price of $106.53. Globe Life has a 12-month low of $38.95 and a 12-month high of $132.00.

Globe Life (NYSE:GL) last issued its quarterly earnings results on Wednesday, February 5th. The company reported $3.14 earnings per share for the quarter, topping the consensus estimate of $3.12 by $0.02. Globe Life had a net margin of 19.04% and a return on equity of 22.91%. Analysts predict that Globe Life will post 12.32 EPS for the current fiscal year.

Globe Life Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, January 31st. Stockholders of record on Monday, January 6th were given a $0.24 dividend. The ex-dividend date was Monday, January 6th. This represents a $0.96 annualized dividend and a dividend yield of 0.78%. Globe Life’s dividend payout ratio (DPR) is presently 8.12%.

Insiders Place Their Bets

In related news, Director Mark A. Blinn sold 3,000 shares of the company’s stock in a transaction that occurred on Monday, January 6th. The shares were sold at an average price of $113.23, for a total transaction of $339,690.00. Following the sale, the director now directly owns 5,122 shares in the company, valued at approximately $579,964.06. This represents a 36.94 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Frank M. Svoboda sold 14,340 shares of the firm’s stock in a transaction on Tuesday, December 3rd. The shares were sold at an average price of $108.80, for a total transaction of $1,560,192.00. Following the completion of the sale, the chief executive officer now owns 16,396 shares in the company, valued at $1,783,884.80. The trade was a 46.66 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 39,788 shares of company stock valued at $4,429,779 in the last 90 days. 1.51% of the stock is owned by insiders.

About Globe Life

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.